Definitive Additional Materials

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No.     )

 

Filed by the Registrant  x    Filed by a Party other than the Registrant  ¨   

Check the appropriate box:

 

¨

  Preliminary Proxy Statement 1

¨

  Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

¨

  Definitive Proxy Statement

x

  Definitive Additional Materials

¨

  Soliciting Material Under Rule 14a-12

Myriad Genetics, Inc.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

 

x

   No fee required.

¨

   Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
   1)   Title of each class of securities to which transaction applies:
    

 

   2)   Aggregate number of securities to which transaction applies:
    

 

   3)   Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
    

 

   4)   Proposed maximum aggregate value of transaction:
    

 

   5)   Total fee paid:
    

 

¨

   Fee paid previously with preliminary materials.

¨

   Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing:
   1)   Amount previously paid:
    

 

   2)   Form, Schedule or Registration Statement No:
    

 

   3)   Filing party:
    

 

   4)   Date Filed:
    

 

 

 

 


*** Exercise Your Right to Vote ***

IMPORTANT NOTICE Regarding the Availability of Proxy Materials

 

          

 

Meeting Information            

 

   
           Meeting Type:     Annual    

MYRIAD GENETICS, INC.

        For holders as of:     October 8, 2012    
          

 

Date:  December 5, 2012

 

 

  Time: 9:00 AM MST

   
          

 

Location:       Offices of Myriad Genetics, Inc.

   
          

     320 Wakara Way

   
       

     Salt Lake City, UT 84108

 

   

  MYRIAD GENETICS, INC.

            

  ATTN: CORPORATE SECRETARY

  320 WAKARA WAY

  SALT LAKE CITY, UT 84108

   

 

You are receiving this communication because you hold shares in the above named company.

   

 

This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).

   

 

We encourage you to access and review all of the important information contained in the proxy materials before voting.

 

     

 

See the reverse side of this notice to obtain proxy materials and voting instructions.

 

M17386-P85483


   

 

Before You Vote  

    
            
        

How to Access the Proxy Materials

 

      Proxy Materials Available to VIEW or RECEIVE:    
 

 

  NOTICE AND PROXY STATEMENT        ANNUAL REPORT

 

  How to View Online:

 

  Have the 12-Digit Control Number available (located on the following page) and visit: www.proxyvote.com.

 

  How to Request and Receive a PAPER or E-MAIL Copy:

 

  If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a   copy. Please choose one of the following methods to make your request:

 

                                 1) BY INTERNET:         www.proxyvote.com

                                 2) BY TELEPHONE:     1-800-579-1639

                                 3) BY E-MAIL*:             sendmaterial@proxyvote.com

 

  *  If requesting materials by e-mail, please send a blank e-mail with the 12-Digit Control Number (located on the following

      page) in the subject line.

 

  Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor.

  Please make the request as instructed above on or before November 20, 2012 to facilitate timely delivery.

 

   
   
   

 

How To Vote  

    
            
        

Please Choose One of the Following Voting Methods

 

          
 

  Vote In Person: Many stockholder meetings have attendance requirements including, but not limited to, the possession of an

  attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for

  meeting attendance. At the meeting you will need to request a ballot to vote these shares.

 

  Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the 12 Digit Control Number available and

  follow the instructions.

 

  Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.

 

    
    

M17387-P85483


Voting Items      

 

The Board of Directors recommends that you vote FOR the following:

       

 

1.      Election of two Class I Directors (or if any nominee is not available for election, such substitute as the Board of Directors may designate) for a three-year term.

     

 

         Nominees:

     

 

         01)  John T. Henderson, M.D.

     

 

         02)  S. Louise Phanstiel

     

 

The Board of Directors recommends you vote FOR the following proposal(s):

  

 

2.      To approve proposed amendments to the Company’s 2010 Employee, Director and Consultant Equity Incentive Plan;

  

 

3.      To approve the adoption of the Company’s 2012 Employee Stock Purchase Plan;

  

 

4.      To approve the adoption of the Company’s 2013 Executive Incentive Plan;

  

 

5.      To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2013; and

  

 

6.      To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the proxy statement.

  

 

In their discretion the proxies are authorized to vote upon such other matters as may properly come before the meeting or any adjournments or postponements thereof.

  

M17388-P85483